Search This Blog

Tuesday, November 27, 2018

TNDM initiated at UBS


Tandem Diabetes initiated with a Neutral at UBS. UBS analyst Matthew Taylor initiated Tandem Diabetes with a Neutral rating and $36 price target.
https://thefly.com/landingPageNews.php?id=2828795
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)